Three dividend-paying pharmaceutical investments to purchase amid the COVID-19 crisis avoid focusing solely on the top contenders for developing vaccines to protect against the dreaded novel coronavirus, since the share price of many of those stocks already have rocketed. However, an exchange-traded fund (ETF) offers exposure to promising vaccine makers as they pursue testing that may result in obtaining approval from the Food and Drug Administration (FDA) within months rather than years.
Bob Carlson, leader of the Retirement Watch investment newsletter, said he firmly recommends Bristol Myers Squibb (NYSE:BMY). He first advised buying the stock on June 29 and it since has risen $57.80 to $62.51, while also paying a $0.45 per share dividend on July 2. Bristol Myers Squibb’s trailing 12-month price-to-earnings (P/E) ratio is 10.87 times its earnings, compared to the Medical — Biomedical and Genetics industry’s ratio of 25.78 times earnings, according to Zacks. As a result, Bristol Myers Squibb trades at a big discount compared to its industry peers as it tries to absorb Celgene. Pfizer Inc (NYSE:PFE), a New York City-based multinational pharmaceutical company, offers a current dividend yield of 3.99% and trades at a P/E ratio of 14.99. That P/E ratio tops Bristol Myers Squibb’s P/E ratio but is much lower than the 25.78 times earnings of the Medical – Biomedical and Genetics industry.
Source: Dividend Investor
Related Articles:
Three Dividend-Paying Pharmaceutical Equities Offer Hope Amid COVID-19 Crisis
Posted by D4L | Tuesday, September 22, 2020 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
At times like this, it is tempting to jump on a bandwagon and buy up the growth stocks, aiming to capitalize on the broader trends. But is t...
-
In today’s near-zero interest rate environment, it’s been tough for investors looking for yield. There are many high-yielding dividend stock...
-
There are some dividend aristocrats which have not only maintained but increased their dividends for over half a century. Having survived ev...
-
Three high dividend stocks to buy now feature a business development company (BDC), a national real estate investment trust (REIT) and the o...
-
The research analysts at Wells Fargo have been searching the markets for the ‘right’ buys, and their picks bear a closer look. They’ve been ...
-
This past year has been the ultimate stress test for dividend stocks. Some companies failed miserably as they either slashed or suspended th...
-
Dividend stocks are a great choice for investors looking for a regular income stream. The best dividend stocks offer a growing payout in add...
-
The dividend-paying cleaning stocks to buy now amid the COVID-19 pandemic should benefit from heightened sanitary expectations by consumers ...
-
Rather than subject themselves to this risk, savvy investors can stabilize their portfolios by taking positions in reliable dividend growth ...
-
The best dividend stocks can generate excellent long-term returns. Even better, investors can buy high-quality dividend stocks when they are...

0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.